MétaCan
Menu
Back to cohort
Record W2789394124 · doi:10.1093/jcag/gwy008.186

A185 IMPACT OF HEPATITIS C ERADICATION USING DIRECT ACTING ANTIVIRALS ON CONCURRENT PRIMARY BILIARY CHOLANGITIS AND ASSOCIATED AUTOIMMUNITY.

2018· article· en· W2789394124 on OpenAlexaffabout
Henry H. Nguyen, Abdullah Al Khathlan, Marvin J. Fritzler, Mark G. Swain

Bibliographic record

VenueJournal of the Canadian Association of Gastroenterology · 2018
Typearticle
Languageen
FieldMedicine
TopicLiver Diseases and Immunity
Canadian institutionsUniversity of Calgary
Fundersnot available
KeywordsAutoimmunityAutoantibodyMedicineImmunologyHepatitis C virusLiver diseaseAutoimmune hepatitisSerologyHepatitis CPrimary biliary cirrhosisInternal medicineGastroenterologyAntibodyHepatitisVirus

Abstract

fetched live from OpenAlex

Chronic Hepatitis C Virus infection has been commonly linked to the development of autoimmunity, in part through activation of B cells. As well, B cells have been shown to play an important pathogenic role in Primary Biliary Cholangitis (PBC). Patients with concurrent HCV infection and PBC have an increased risk of more rapidly progressive disease, although the mechanism underlying this effect is poorly understood. However, it seemed plausible that HCV infection could enhance PBC-associated autoimmunity thereby worsening disease. Therefore, the aim of our study was to determine the impact of HCV eradication upon serological markers of autoimmunity (ie. autoantibody production) and liver biochemistry in PBC patients infected with HCV. We identified 3 HCV-infected patients who also had significant serum AMA titers, and were followed in the University of Calgary Liver Unit. All 3 patients were treated with non-interferon based direct-acting antiviral (DAA) therapies. One patient was on UDCA therapy (13 mg/kg/day) during the treatment period (elevated serum alkaline phosphatase levels). The remaining two patients were not on UDCA therapy due to intolerance in one, and normal serum alkaline phosphatase levels in the other. Virological response to DAA’s was assessed during and after therapy in all patients using a HCV Quantitative Nucleic Acid Test (Abbott), and serum liver biochemistries measured by Calgary Laboratory Services. Autoantibodies associated with autoimmune liver diseases, including PBC specifically, were measured before, during and after DAA treatment (Mitogen Advanced Diagnostics Laboratory, Calgary AB, Canada). All patients achieved a sustained virological response (SVR), as determined by a negative HCV RNA test 12 weeks post-DAA therapy. Titres of antimitochondrial antibodies (AMA-M2), anti- branched-chain 2-oxo-acid dehydrogenase complex and 2-oxo glutarate dehydrogenase complex (anti-3E-BPO), and anti- tripartite motif-containing protein 21 (TRIM21/Ro52) remained unchanged despite successful HCV eradication. Two of three patients exhibited a transient decrease in some autoantibody titres during DAA treatment, but these returned to baseline levels post-DAA therapy. Our results suggest that ongoing HCV infection is not a significant driver of PBC-related autoimmunity/autoantibody production. CIHRCal Wenzel Family Foundation Chair in Hepatology,

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.276
Teacher spread0.259 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueJournal of the Canadian Association of GastroenterologySame topicLiver Diseases and ImmunityFrench-language works237,207